English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications is shared by a diverse group of medical professionals, including but not limited to physicians and basic scientists in several fields, as well as members of industry, regulatory bodies, and patients. However, no organizational structure is available to regularly bring these stakeholders together to discuss the latest findings and the most productive strategies to ensure that the potential benefits of TRT are realized. Recognizing the need for a forum to discuss the advances and challenges of TRT relating to availability, supporting technology, and interdisciplinary training and research, the National Cancer Institute (NCI) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted a joint workshop on March 18 and 19, 2013, at the National Institutes of Health campus in Bethesda, Maryland (1). Plans for the workshop were initiated in 2012 by Dr. Frederic Fahey, SNMMI president, and Dr. Jacek Capala of the NCI, and the 2-d event was cochaired by Dr. Fahey and Dr. Katherine Zukotynski. The event was designed to bring a small but diverse group of stakeholders together (Fig. 1) to discuss contemporary TRT in both structured and open-forum formats, to assess approaches for collaboration, and to evaluate strategies to bring the most promising therapies into routine clinical use. This white paper briefly reviews the discussion on TRT that took place at the workshop and offers next-step recommendations from attendees as summarized in presentations by subject matter experts.

the journal of nuclear medicine

Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging